Replies to post #245024 on Avid Bioservices Inc (CDMO)

[purpledawgs]

Plus, they said they have enough enrolled already for the two triggering events and unblinding!

"As of today, more than 90% of the planned number of patients have been enrolled in the Phase III SUNRISE trial, representing a sufficient number of patients required to trigger the two pre-planned interim analyses as well as the final analysis for trial unblinding."

PD

[biopharm]

Over 90% enrolled. That is more than 525 patients in SUNRISE. That sounds good to me.

... over 90% also equals 97% ... I wonder close